{"schema_version":"secwatch.filing_event.v1","accession":"0001193805-24-001079","form_type":"8-K","ticker":"IMUX","cik":"0001280776","company_name":"IMMUNIC, INC.","filed_at":"2024-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.453847+00:00","generated_at":"2026-05-31T06:34:48.409173+00:00","sec_items":["1.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Immunic extends Executive Chairman Dr. Duane Nash's term to Dec 2025 with salary increase","bullets":["Term of Executive Chairman Duane Nash extended to December 31, 2025 via Addendum No. 6.","Monthly base salary raised to $33,987 from $32,368, inclusive of board retainer.","Addendum effective August 29, 2024; all other employment terms unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001193805-24-001079","json":"https://secwatch.observer/filing/0001193805-24-001079.json","markdown":"https://secwatch.observer/filing/0001193805-24-001079.md","text":"https://secwatch.observer/filing/0001193805-24-001079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524001079/0001193805-24-001079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524001079/e663859_8k-immunic.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:34:48.409173+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}